New

Revolutionizing Healthcare with AI-Powered Precision and Insight.

X

Logo

The Edge Bio

Global Health

The Most Broadly Embraced AI in Worldwide Healthcare

Learn More
20M+

Lives Impacted

90+

Countries, 55 for TB use case

3100+

Sites, 1900+ sites for TB use case

60%

Cost saving on confirmatory tests

$200

Cost saved per notified case

99%

reduction in TAT to confirmed diagnosis; from 3 weeks to 2 hrs

29%

Additional TB cases detected via Incidental pathway

750k +

TB presumptive cases flagged, 12 million CXRs processed

From Innovation to Impact Shaping the Future of Global Health with AI

Complete Tuberculosis Detection & Treatment for All Ages

The Edge Bio's AI-powered solutions, qXR and qTrack, set the gold standard in tuberculosis care, transforming detection and management on a global scale. Recognized for their accuracy and widely implemented worldwide, our solutions boost TB detection rates and optimize healthcare workflows.

Through the seamless integration of AI into diagnostics, we enable swift and accurate TB identification, ensuring timely treatment and life-saving interventions. Our methodology enhances the efficiency and utilization of healthcare resources while contributing significantly to global TB elimination initiatives—especially in detecting pediatric cases.

Pediatric tuberculosis remains a significant global health concern, frequently resulting in delayed diagnosis due to vague symptoms and diagnostic limitations. The Pediatric TB algorithm within qXR enhances early detection and diagnostic precision. Additionally, the Pediatric TB package integrates WHO clinical forms into the qTrack platform, helping streamline treatment workflows and ensure timely, effective care for children.

Comprehensive TB Detection & Management: For Adult and Pediatric TB

Silicosis (Pneumoconiosis) Diagnosis and Treatment

The Edge Bio’s cutting-edge AI technologies, such as qXR, are revolutionizing lung health by precisely detecting intricate patterns of silicosis.

Silicosis is a serious lung condition resulting from prolonged inhalation of silica dust, typically encountered in sectors like mining and construction. It causes irreversible lung scarring and severe respiratory problems—and currently, there is no cure. One of the most alarming aspects of silicosis is its strong association with tuberculosis (TB). The lung damage caused by silicosis significantly increases vulnerability to TB infection, creating a dangerous synergy where each disease amplifies the harm of the other.

The Edge Bio’s AI solutions play a crucial role in the early detection of both silicosis and tuberculosis. By identifying disease markers at an early stage, these tools enable timely medical intervention, helping to slow progression and enhance patient outcomes. In regions with limited access to experienced radiologists, our technology becomes especially vital—bridging diagnostic gaps and strengthening efforts to combat both silicosis and TB.

Silicosis (Pneumoconiosis) Diagnosis and Treatment

Robust and Enduring Healthcare Systems

The Edge Bio’s AI solutions identify tuberculosis and generate comprehensive radiological analyses, including lung nodules, signs of heart failure, silicosis, and pneumothorax, offering thorough diagnostic reports that enhance healthcare initiatives. Seamlessly integrating with X-ray equipment and optimizing workflows, The Edge Bio ensures efficient screening processes and smooth interoperability with hospital IT systems and national health platforms.

The platform provides user-friendly dashboards to track program metrics across district and national levels. Additionally, its care management system functions as a compact PACS, facilitating radiology image storage, digital viewing, and reporting capabilities.

qTrack enhances remote support with teleradiology, enabling seamless sharing of images, AI results, and patient data, and facilitating two-way communication between healthcare departments. It digitizes radiology workflows, eliminating the need for physical prints and offering easy image access on-site or remotely.

Robust and Enduring Healthcare Systems

Strengthening International Health Safeguards

The Edge Bio applies its expertise to disaster management and pandemic readiness by providing advanced AI tools such as qMSK (for fracture detection) and qXR, enabling rapid emergency response and optimized resource allocation. Our innovations facilitate quick musculoskeletal evaluations and real-time disease monitoring, delivering vital support to healthcare providers and public health officials during crises.

Throughout the pandemic, our solutions were instrumental, highlighting our dedication to global health security. The Edge Bio’s technologies also support teleradiology reporting, a critical tool during pandemics or disasters that aids local healthcare workers facing limited resources and capacity.

Strengthening International Health Safeguards

Customer Success and Support

The Edge Bio is dedicated to helping clients maximize the value of our products and services to meet their clinical and business objectives. Every client is supported by a dedicated success partner who is well-versed in care pathways and committed to assisting healthcare providers throughout the AI implementation journey.

We provide personalized onboarding, 24/7 support, and ongoing education to address all your needs. Our dedicated team of engineers and clinicians ensures seamless integration and efficient handling of any issues throughout your project. Regular check-ins, reviews, and detailed tracking of interactions and success metrics help us deliver continuous improvements and maximize the benefits of our solutions.

Customer Success and Support
Whatsapp
X
whatsapp-icon + 447463151997

Please send your query or requirements in detail via whatsapp, and we will respond shortly.
Thank you!